305 related articles for article (PubMed ID: 23966390)
1. Pattern recognition receptor MDA5 modulates CD8+ T cell-dependent clearance of West Nile virus from the central nervous system.
Lazear HM; Pinto AK; Ramos HJ; Vick SC; Shrestha B; Suthar MS; Gale M; Diamond MS
J Virol; 2013 Nov; 87(21):11401-15. PubMed ID: 23966390
[TBL] [Abstract][Full Text] [Related]
2. The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection.
Errett JS; Suthar MS; McMillan A; Diamond MS; Gale M
J Virol; 2013 Nov; 87(21):11416-25. PubMed ID: 23966395
[TBL] [Abstract][Full Text] [Related]
3. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system.
Szretter KJ; Daffis S; Patel J; Suthar MS; Klein RS; Gale M; Diamond MS
J Virol; 2010 Dec; 84(23):12125-38. PubMed ID: 20881045
[TBL] [Abstract][Full Text] [Related]
4. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1.
Fredericksen BL; Keller BC; Fornek J; Katze MG; Gale M
J Virol; 2008 Jan; 82(2):609-16. PubMed ID: 17977974
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 3 has a protective role against West Nile virus infection.
Daffis S; Samuel MA; Suthar MS; Gale M; Diamond MS
J Virol; 2008 Nov; 82(21):10349-58. PubMed ID: 18715906
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons.
Shrestha B; Pinto AK; Green S; Bosch I; Diamond MS
J Virol; 2012 Sep; 86(17):8937-48. PubMed ID: 22740407
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of Tissue-Specific CD8
Aguilar-Valenzuela R; Netland J; Seo YJ; Bevan MJ; Grakoui A; Suthar MS
J Virol; 2018 May; 92(10):. PubMed ID: 29514902
[TBL] [Abstract][Full Text] [Related]
8. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.
Gorman MJ; Poddar S; Farzan M; Diamond MS
J Virol; 2016 Sep; 90(18):8212-25. PubMed ID: 27384652
[TBL] [Abstract][Full Text] [Related]
9. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo.
Szretter KJ; Daniels BP; Cho H; Gainey MD; Yokoyama WM; Gale M; Virgin HW; Klein RS; Sen GC; Diamond MS
PLoS Pathog; 2012; 8(5):e1002698. PubMed ID: 22589727
[TBL] [Abstract][Full Text] [Related]
10. IPS-1 is essential for the control of West Nile virus infection and immunity.
Suthar MS; Ma DY; Thomas S; Lund JM; Zhang N; Daffis S; Rudensky AY; Bevan MJ; Clark EA; Kaja MK; Diamond MS; Gale M
PLoS Pathog; 2010 Feb; 6(2):e1000757. PubMed ID: 20140199
[TBL] [Abstract][Full Text] [Related]
11. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.
Sitati EM; Diamond MS
J Virol; 2006 Dec; 80(24):12060-9. PubMed ID: 17035323
[TBL] [Abstract][Full Text] [Related]
12. STING is required for host defense against neuropathological West Nile virus infection.
McGuckin Wuertz K; Treuting PM; Hemann EA; Esser-Nobis K; Snyder AG; Graham JB; Daniels BP; Wilkins C; Snyder JM; Voss KM; Oberst A; Lund J; Gale M
PLoS Pathog; 2019 Aug; 15(8):e1007899. PubMed ID: 31415679
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection.
Thackray LB; Shrestha B; Richner JM; Miner JJ; Pinto AK; Lazear HM; Gale M; Diamond MS
J Virol; 2014 Oct; 88(19):11007-21. PubMed ID: 25031348
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection.
Brien JD; Daffis S; Lazear HM; Cho H; Suthar MS; Gale M; Diamond MS
PLoS Pathog; 2011 Sep; 7(9):e1002230. PubMed ID: 21909274
[TBL] [Abstract][Full Text] [Related]
15. West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5.
Zhang HL; Ye HQ; Liu SQ; Deng CL; Li XD; Shi PY; Zhang B
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659477
[TBL] [Abstract][Full Text] [Related]
16. MAVS regulates the quality of the antibody response to West-Nile Virus.
O'Ketch M; Williams S; Larson C; Uhrlaub JL; Wong R; Hall B; Deshpande NR; Schenten D
PLoS Pathog; 2020 Oct; 16(10):e1009009. PubMed ID: 33104760
[TBL] [Abstract][Full Text] [Related]
17. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.
Daffis S; Samuel MA; Suthar MS; Keller BC; Gale M; Diamond MS
J Virol; 2008 Sep; 82(17):8465-75. PubMed ID: 18562536
[TBL] [Abstract][Full Text] [Related]
18. West Nile Virus Infection Blocks Inflammatory Response and T Cell Costimulatory Capacity of Human Monocyte-Derived Dendritic Cells.
Zimmerman MG; Bowen JR; McDonald CE; Pulendran B; Suthar MS
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534040
[TBL] [Abstract][Full Text] [Related]
19. Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals.
Daniels BP; Holman DW; Cruz-Orengo L; Jujjavarapu H; Durrant DM; Klein RS
mBio; 2014 Aug; 5(5):e01476-14. PubMed ID: 25161189
[TBL] [Abstract][Full Text] [Related]
20. MAVS Expressed by Hematopoietic Cells Is Critical for Control of West Nile Virus Infection and Pathogenesis.
Zhao J; Vijay R; Zhao J; Gale M; Diamond MS; Perlman S
J Virol; 2016 Aug; 90(16):7098-7108. PubMed ID: 27226371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
